Rating History for Pacira Pharmaceuticals (PCRX) by Oppenheimer

More Stocks Rated by Oppenheimer | Latest Ratings for PCRX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/8/2026 Les Sulewski Downgrade Perform
(Outperform)		 N/A
(N/A)		 25.20
(36.34)		 44.21% Details